-
-
-
-
-
-
-
UPDATE - Quince Therapeutics Announces Clinically Meaningful Improvements Across Functional, Hemodynamic and Biomarker Measures in Phase 2 Study in PAH and PH-ILD
-
-
-
-
-
-
-
Quince Therapeutics Provides Business Update and Reports Fourth Quarter and Fiscal 2023 Financial Results
-
-
-
-
-
-
-
Quince Therapeutics Appoints Dr. Charles S. Ryan as President
-
-
-
-
-
-
-
Quince Therapeutics Board of Directors Unanimously Rejects Unsolicited Proposal from Echo Lake Capital
-
-
-
-
-
-
-
Echo Lake Capital Offers to Acquire Quince Therapeutics, Inc.
-
-
-
-
-
1,188,058 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

